ZOLEDREN (Zoledron or zoledronic acid, or Biphosphonate zoledronic): Zoledronic acid, belongs to a class of medications called bisphosphonates. It acts by slowing the breakdown of the bone, increasing the density (thickness) of the bones and decreasing the amount of calcium that the bones release in the blood.
Zoledronic acid is used to prevent or treat osteoporosis (a condition in which bones become thin and weak, and fracture easily).
Or to prevent it when glucocorticoids (dexamethasone, prednisolone, etc.) are consumed to treat bone disease, to treat high blood calcium levels, combined with cancer chemotherapy to treat bone damage, is used as a regulator of metabolism Osteo-Articular, in supportive therapies and adjuvants in the specific treatments of osteo-articular pathologies (Osteoarthritis and Arthritis), bone marrow, navicular syndromes (in less than 6 months), sacs, transverse spinal arthrosis, fractures, acceleration of maturity Osteitis, third phalangeal osteitis, sesamoiditis, exercise intolerance due to immature osteoarthritis, ostial weakness syndrome, osteochondritis desiccant (OCD), epiphysitis, and basically in any process where it is necessary to introduce calcium in a worn bone.